BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
37 hedge funds and large institutions have $9.04M invested in BRAINSTORM CELL THERAPUTC in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less capital invested
Capital invested by funds: $9.38M → $9.04M (-$342K)
5% less funds holding
Funds holding: 39 → 37 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
37
Holding in Top 10
1
Calls
$65K
Puts
$39K
Top Buyers
| 1 | +$70.6K | |
| 2 | +$47K | |
| 3 | +$34.1K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$29.3K |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
+$23K |
Top Sellers
| 1 | -$163K | |
| 2 | -$101K | |
| 3 | -$87K | |
| 4 |
Goldman Sachs
New York
|
-$54K |
| 5 |
Cerity Partners
New York
|
-$49K |